Skip to main content

and
  1. Article

    Open Access

    Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial

    Universal coverage of vaccines alone cannot be relied upon to protect at-risk populations in lower- and middle-income countries against the impact of the coronavirus disease 2019 (COVID-19) pandemic and newer ...

    Sanjeev Sinha, Anuj Ajayababu, Himanshu Thukral in Infectious Diseases and Therapy (2022)

  2. Article

    Open Access

    Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial

    Sanjeev Sinha, Anuj Ajayababu, Himanshu Thukral in Infectious Diseases and Therapy (2023)